Pure Global

HCV Test and Treat Utilizing Simplified HCV Patient Education - Trial NCT05582681

Access comprehensive clinical trial information for NCT05582681 through Pure Global AI's free database. This Phase 4 trial is sponsored by Weill Medical College of Cornell University and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05582681
Phase 4
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT05582681
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
HCV Test and Treat Utilizing Simplified HCV Patient Education

Study Focus

Hepatitis C

Cepheid POC HCV Viremia (RNA) test

Interventional

diagnostic test

Sponsor & Location

Weill Medical College of Cornell University

Long Island City,New York,New York, United States of America

Timeline & Enrollment

Phase 4

Nov 11, 2022

Oct 01, 2027

200 participants

Primary Outcome

Number of subjects who initiated treatment within 8-week window from enrollment.

Summary

The study hypothesis is that the test and treat model utilizing video-based patient education
 will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment
 completion.

ICD-10 Classifications

Acute hepatitis C
Chronic viral hepatitis C
Viral hepatitis
Chronic viral hepatitis
Unspecified viral hepatitis

Data Source

ClinicalTrials.gov

NCT05582681

Non-Device Trial